FOLR1 Regulates the Malignant Progression of Glioblastoma through the SRC/ERK1/2 Axis

Xueshan Jia1, Weihang Liang2, Junya Yang3

  • 1School of Public Health, Zhengzhou University, No. 100, Science Avenue, High-tech Zone, Zhengzhou, Henan 450001, China.

Abstract

Insights

Folate receptor alpha (FOLR1) promotes glioblastoma (GBM) growth by activating the SRC/ERK1/2 pathway. Targeting FOLR1 may offer a new therapeutic strategy for this aggressive brain cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Glioblastoma (GBM) is an aggressive brain tumor with limited therapeutic options.
  • Folate receptor alpha (FOLR1) has been implicated in cancer development.
  • Understanding FOLR1's role in GBM is crucial for developing new treatments.

Purpose of the Study:

  • To investigate the expression and prognostic significance of FOLR1 in GBM.
  • To explore the role of FOLR1 in GBM cell growth and proliferation.
  • To elucidate the involvement of the SRC/ERK1/2 signaling pathway in FOLR1-mediated GBM progression.

Main Methods:

  • Analysis of FOLR1 expression in public databases and GBM patient samples.
  • In vitro cell experiments to assess the impact of FOLR1 expression on GBM cell growth.
  • Gene co-expression network analysis and pathway enrichment analysis.
  • Investigation of the SRC/ERK1/2 signaling axis in relation to FOLR1 in GBM cells.

Main Results:

  • FOLR1 is highly expressed in GBM and associated with poor patient prognosis.
  • Overexpression of FOLR1 enhances GBM cell growth; reduced expression inhibits it.
  • FOLR1 activates the SRC/ERK1/2 signaling pathway in GBM.
  • Pathway enrichment analysis revealed involvement in lysosome and toxoplasmosis pathways.

Conclusions:

  • FOLR1 plays a critical role in GBM pathogenesis by promoting cell growth and activating the SRC/ERK1/2 signaling axis.
  • Targeting FOLR1 and the SRC/ERK1/2 pathway presents a potential therapeutic strategy for GBM.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K